Development of a protease-resistant ADAMTS13 to improve stability against proteolytic degradation. [PDF]
DeYoung V +6 more
europepmc +1 more source
Plasmin-mediated proteolysis of von Willebrand factor in patients with acute and chronic liver disease. [PDF]
El Otmani H +6 more
europepmc +1 more source
Genetic Susceptibility in Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease: A Case-Control Study. [PDF]
Mavrikou I +16 more
europepmc +1 more source
Successful Treatment of refractory Thrombotic Thrombocytopenic Purpura With The Monoclonal Antibody Rituximab :A case Report [PDF]
Much of thrombotic thrombocytopenic purpura (TTP) is attributed to the presence of an autoantibody to ADAMTS-13, the metalloprotease that degrades ultralarge von Willebrand protein multimers.
فتحی, افشین +1 more
core
Immune-mediated thrombotic thrombocytopenic purpura with systemic lupus erythematosus: clinical features and outcome. [PDF]
Weisinger J +17 more
europepmc +1 more source
Anti-ADAMTS13 Antibodies Trajectory is Associated With ADAMTS13 Recovery in Immune-Mediated TTP. [PDF]
Robert M +29 more
europepmc +1 more source
Challenges in diagnosing thrombotic thrombocytopenic purpura. [PDF]
Jacobs JW, Booth GS, Adkins BD.
europepmc +1 more source
Is COVID-19 Coagulopathy a Thrombotic Microangiopathy? A Prospective, Observational Study. [PDF]
Silingardi M +14 more
europepmc +1 more source
Immune-coagulation dynamics in severe COVID-19 revealed by autoantibody profiling and multi-omics integration. [PDF]
Ambikan AT +8 more
europepmc +1 more source
Advances in Research on the Release of von Willebrand Factor from Endothelial Cells through the Membrane Attack Complex C5b-9 in Sepsis. [PDF]
Liu Y +9 more
europepmc +1 more source

